Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23


Joan Seoane

Vall d'Hebron Institute of Oncology (VHIO)
Universitat Autònoma de Barcelona (UAB)


Joan Seoane is a Group Leader and Director of the Translational Research program at the Vall d'Hebron Institute of Oncology (VHIO) within the Vall d'Hebron University Hospital since 2011.

In 1998, Joan obtained his PhD in Biochemistry and Molecular Biology from the University of Barcelona. Previously, in 1993, he obtained his BSc degree in Chemistry. Joan joined the Memorial Sloan-Kettering Cancer Center (MSKCC) in New York as a post-doctoral fellow in 1998.

From 1998 to 2001, he worked as a Research Fellow and subsequently, from 2001 to 2003, as a Research Associate. He was appointed ICREA Research Professor in 2004 and joined VHIO.

In 2007, he became a member of the EMBO Young Investigator program and the recipient of a European Research Council (ERC) grant in 2008. Later, he obtained two ERC Proof of Concept grants (2011, 2013). In 2008, he became Board member of the European Association of Cancer Research (EACR) and Professor of the Autonomous University of Barcelona.

In 2016, he became Secretary General of the EACR.

ESMO 2017 Congress

"Translational research is paramount in driving novel and more effective therapeutic strategies against cancer. While we are collectively potentiating and rendering innovative treatment approaches more precise, we must continue to accelerate our efforts by closely connecting cancer researchers with medical oncologists.

The ESMO Congress Translational Research Track represents an important platform to do just that. Not only will our specially selected experts tackle the role and relevance of the tumour microenvironment, genomic instability in cancer and the development of increasingly powerful therapeutics; they will deliver the very latest insights into cancer evolution and metastatic spread and report on the latest discovery aimed at better deciphering the molecular complexity of inter‐ and intra‐tumour heterogeneity.

Our track will promote the vital cross‐talk between researchers and clinical colleagues, foster the timely exchange of insights from bench to bedside, provide ´finger on the pulse´ perspectives on current opportunities and challenges, as well as balance expectations with current realities."

Joan Seoane


Joan Seoane was the Translational Research Track Co-Chair of the ESMO 2017 Congress, which took place in Madrid, Spain (8-12 September 2017).

View ESMO 2017 Congress meeting resources

Last update: April 2017

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.